Pharmacotherapy of vertigo
https://doi.org/10.30629/2618-6667-2017-76-115-122
Abstract
The aim was to review the main types of vertigo and the basic strategy of treatment. Results: there are fve main types of vertigo: vestibular, postural, lipotimic, cervicogenic and functional. The notion of persisten postural-perceptive verigo was accepted last years. Three clinical situations concerning vertigo are considered: 1) single long-term episode of vertigo commonly vestibular; 2) recurrent episodes of vertigo; 3) chronic vertigo. Conclusion: ethiopathogenetic approach to treatment of vertigo is based on syndrome and nosological assessment.
About the Authors
Achcha Chimagomedova
Russian Medical Academy of Continuous Professional Education, Moscow
Russian Federation
postgraduate, department of neurology
Russian Federation
postgraduate, department of neurology
Oleg Levin
Russian Medical Academy of Continuous Professional Education, Moscow
Russian Federation
PhD, MD, professor, head of department of neurology
Russian Federation
PhD, MD, professor, head of department of neurology
References
1. Shtul'man D.R., Levin O.S. Nevrologija. Spravochnik prakticheskogo vracha. 4-e izdanie. M: Medpress-inform, 2005:908. (In Russ.).
2. Brandt T. Vertigo. Neurologic Disorders. Course and Treatment. Eds T. Brandt et al. San Diego, 1996:117–134.
3. Bronstein A., Lempert T. Dizziness. Cambridge University Press, 2007:221.
4. Neuhauser H.K., von Brevern M., Radtke A., Lezius F., Feldmann M., Ziese T., Lempert T. Epidemiology of vestibular vertigo. Neurology. 2005;65:898–904. doi: 10.1212/01.wnl.0000175987.59991.3d
5. Marchetti G.F., Whitney S.L. Older adults and balance dysfunction. Neurol. Clin. 2005;23:785–805. doi: 10.1016/j.ncl.2005.01.009
6. Lavpov A.Ju., Shtul'man D.P., Jahno N.N. Golovokpuzhenie u pozhilyh. Nevrol. zhurn. 2000;5:39–47. (In Russ.).
7. Epley J.M. The canalith repositioning procedure: for treatment of benign paroxysmal positional vertigo. Otolaryngol. Head Neck Surg. 1992;107:399–404.
8. Furman J.M., Cass S.P. Benignparoxysmalpositionalvertigo. N. Engl. J. Med. 1999;341:1590–1596. doi: 10.1056/NEJM199911183412107
9. Baloh R.W. Vestibular neuritis. N. Engl. J. Med. 2003;348:1027–1032. doi: 10.1056/NEJMcp021154
10. Norrving B., Magnusson M., Holtas S. Isolated acute vertigo in the elderly; vestibular or vascular disease? Acta Neurol. Scand. 1995;91:48.
11. James A., Thorp M. Meniere’s disease. Clin. Evid. 2003;9:565–573.
12. Hain T.C., Yacovino D. Pharmacologic treatment of persons with dizziness. Neurol. Clin. 2005;23:831–853. doi: 10.1016/j.ncl.2005.01.012
13. Eggers S.D.Z. Migraine-related vertigo. Curr. Neurol. Neurosci Reports 2006;6:106–115.
14. Jacob R.G., Furman J.M., Durrant J.D. et al. Panic, agoraphobia, and vestibular dysfunction Am. J. Psychiatry. 1996;153:503–512. doi: 10.1176/ajp.153.4.503
15. Lavrov A.Ju. Primenenie betaserka v nevrologicheskoj praktike. Nevpol. zhurn. 2001;2:35–38. (In Russ.).
16. Hain T.C., Uddin M. Pharmacological treatment of vertigo. CNS Drugs. 2003;17:85–100.
17. Swartz R., Longwell P. Treatment of vertigo. Am. Fam. Physician. 2005; 71:1115–1129.
18. Albera R., Ciuffolotti R., Di Cicco M. et al. Doubled-blind randomized multicenter study comparing the effect of betahistine and flunarisine on the dizziness handicap in patients with recurrent vestibular vertigo. Acta Oto-Laryngology. 2003;123:588–593.
19. Schneider D., Kiessling B., Wieczorek M. et al. Influence of 3 antivertiginous medications on the vigilance of healthy volunteers. J. Clin. Pharmacol. Therapeutics. 2003;41:171–181.
20. Seipel J.H., Fisher R., Blatchley R.J. Rheoencephalographic and other studies of betahistine in humans. J. Clin. Pharmacology. 1977;17:140–161.
21. Holstein N. Ginkgo extract helps patients suffering from tinnitus. Review of the literature shows: tinnitus decreases. MMW Fortschr. Med. 2000;142(47):46.
22. Lacour M., Ez-Zaher L., Raymond J. Plasticity mechanisms in vestibular compensation in the cat are improved by an extract of Ginkgo biloba (EGb 761). Pharmacol. Biochem Behav. 1991;40(2):367–379.
23. Orendorz-Fraczkowska K., Pośpiech L., Gawron W. Results of combined treatment for vestibular receptor impairment with physical therapy and Ginkgo biloba extract (Egb 761). Otolaryngol. Pol. 2002;56(1):83–88.
24. Hilton M., Pinder D. The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo. Cochrane Database Syst. Rev. 2004(3):CD003162
25. Cohen H.S., Kimball K.T. Increased independence and decreased vertigo after vestibular rehabilitation. Otolaryngol. Head Neck Surg. 2003;128:60–70. doi:10.1067/mhn.2003.23
26. Mira E., Guidetti G., Ghilardi L., Fattori B., Malannino N., Maiolino L., Mora R., Ottoboni S., Pagnini P., Leprini M., Pallestrini E., Passali D., Nuti D., Russolo M., Tirelli G., Simoncelli C., Brizi S., Vicini C., Frasconi P. Betahistine in the treatment of peripheral vestibular vertigo. Eur. Arch. Oto-Rhino-Laringology. 2003; 260:73–77. doi: 10.1007/s00405-002-0524-4
27. James A., Burton M.J. Betahistine for Meniere disease or syndrome. Cochrane Database Syst. Rev. 2000(3):CD001873.
28. Neuhauser H., Leopold M., von Brevern M., Arnold G., Lempert T. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology. 2001;56:436–441.
29. Staab J.P., Ruckenstein M.J., Solomon D., Shepard N.T. Serotonin reuptake inhibitors for dizziness with psychiatric symptoms. Arch. Otolaryngol. Head Neck Surg. 2002;128:554–560.
Review
For citations:
Chimagomedova A., Levin O. Pharmacotherapy of vertigo. Psychiatry (Moscow) (Psikhiatriya). 2017;(76):115-122. (In Russ.) https://doi.org/10.30629/2618-6667-2017-76-115-122
Views:
812
Email this article 
